These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38695911)

  • 1. [Benign mesothelial tumors].
    Tischoff I; Theile A
    Pathologie (Heidelb); 2024 Sep; 45(5):324-332. PubMed ID: 38695911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The significance of BAP1 and MTAP/CDKN2A expression in well-differentiated papillary mesothelial tumour: a series of 21 cases and a review of the literature.
    Hassan A; Prabhakaran S; Pulford E; Hocking AJ; Godbolt D; Ziad F; Pandita A; Wessels A; Hussey M; Russell PA; Klebe S
    Pathology; 2024 Aug; 56(5):662-670. PubMed ID: 38789301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L1CAM expression in cystic mesothelial lesions: a comparison with adenomatoid tumours, well-differentiated papillary mesothelial tumours and malignant mesotheliomas.
    Karpathiou G; Casteillo F; Dridi M; Papoudou-Bai A; Dumollard JM; Peoc'h M
    Histopathology; 2021 Aug; 79(2):272-274. PubMed ID: 33847416
    [No Abstract]   [Full Text] [Related]  

  • 4. [Well-differentiated papillary mesothelial tumour of the tunica vaginalis: A case report].
    Fang Y; Li Q; Huang Z; Lu M; Hong K; Zhang S
    Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Aug; 56(4):741-744. PubMed ID: 39041574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localized and diffuse mesotheliomas of the genital tract and peritoneum in women. A clinicopathologic study of nineteen true mesothelial neoplasms, other than adenomatoid tumors, multicystic mesotheliomas, and localized fibrous tumors.
    Goldblum J; Hart WR
    Am J Surg Pathol; 1995 Oct; 19(10):1124-37. PubMed ID: 7573671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Characteristics and Outcomes of Patients with Well-Differentiated Papillary Peritoneal Mesothelial Tumors.
    Offin M; Aguirre N; Yang SR; Sauter JL; Karagkounis G; Mohamed M; Cercek A; Kundra R; Zhang Y; Wang HM; Morris MP; Ladanyi M; Nash GM; Zauderer MG
    Ann Surg Oncol; 2024 Nov; 31(12):7973-7977. PubMed ID: 39167353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New developments in mesothelial pathology.
    Churg A
    Histopathology; 2024 Jan; 84(1):136-152. PubMed ID: 37694811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BAP1 Loss is a Useful Adjunct to Distinguish Malignant Mesothelioma Including the Adenomatoid-like Variant From Benign Adenomatoid Tumors.
    Erber R; Warth A; Muley T; Hartmann A; Herpel E; Agaimy A
    Appl Immunohistochem Mol Morphol; 2020 Jan; 28(1):67-73. PubMed ID: 30640754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid papillary mesothelial tumor.
    Churg A; Le Stang N; Dacic S; Pissaloux D; Begueret H; Dartigues P; Giusiano-Courcambeck S; Sequeiros R; Pairon JC; Tirode F; Galateau-Sallé F
    Mod Pathol; 2022 Jan; 35(1):69-76. PubMed ID: 34480081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneal adenomatoid (microcystic) mesothelioma.
    Mori D; Kido S; Hiraki M; Sumi K; Ureshino N; Masuda M; Nabeshima K; Akashi M
    Pathol Int; 2020 Nov; 70(11):876-880. PubMed ID: 32881200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidental finding of multiple well-differentiated papillary mesotheliomas in peritoneum.
    Jakobsen M; Engvad B; Jensen T; Marcussen N
    APMIS; 2016 Apr; 124(4):333-4. PubMed ID: 26766140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Well differentiated papillary mesothelial tumor: a new name and new problems.
    Churg A; Galateau-Salle F
    Mod Pathol; 2022 Oct; 35(10):1327-1333. PubMed ID: 35440764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and Immunohistochemical Testing in Mesothelioma and Other Mesothelial Lesions.
    Hung YP; Chirieac LR
    Arch Pathol Lab Med; 2024 May; 148(5):e77-e89. PubMed ID: 38190277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Well-differentiated papillary mesothelioma of the peritoneum is genetically defined by mutually exclusive mutations in TRAF7 and CDC42.
    Stevers M; Rabban JT; Garg K; Van Ziffle J; Onodera C; Grenert JP; Yeh I; Bastian BC; Zaloudek C; Solomon DA
    Mod Pathol; 2019 Jan; 32(1):88-99. PubMed ID: 30171198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesotheliomas and Benign Mesothelial Tumors: Update on Pathologic and Imaging Findings.
    Bonde A; Singh R; Prasad SR; Kamireddy D; Aggarwal A; Ramani N; Saboo S; Shanbhogue K; Dasyam AK; Katabathina VS
    Radiographics; 2023 Mar; 43(3):e220128. PubMed ID: 36757881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collagenous Spherulosis in Well-Differentiated Papillary Mesothelioma in a Female With Multilocular Peritoneal Inclusion Cysts.
    AbdullGaffar B; Raman LG
    Int J Surg Pathol; 2019 Jun; 27(4):427-431. PubMed ID: 30522362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A diagnostic approach to paratesticular lesions with tubulopapillary architecture: a series of 16 serous borderline tumors/low-grade serous carcinoma and 14 well-differentiated papillary mesothelial tumors and mesothelioma.
    Zafar R; Schrader LJ; Cheville JC; Schoolmeester JK; Roden AC; Aubry MC; Yi ES; Raghunathan A; Herrera-Hernandez L; Thompson RH; Boorjian SA; Leibovich BC; Keeney GL; Jimenez RE; Gupta S
    Hum Pathol; 2022 Oct; 128():31-47. PubMed ID: 35809685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic profiling of malignant peritoneal mesothelioma reveals recurrent alterations in epigenetic regulatory genes BAP1, SETD2, and DDX3X.
    Joseph NM; Chen YY; Nasr A; Yeh I; Talevich E; Onodera C; Bastian BC; Rabban JT; Garg K; Zaloudek C; Solomon DA
    Mod Pathol; 2017 Feb; 30(2):246-254. PubMed ID: 27813512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRAF7 mutations and immunohistochemical study of uterine adenomatoid tumor compared with malignant mesothelioma.
    Itami H; Fujii T; Nakai T; Takeda M; Kishi Y; Taniguchi F; Terada C; Okada F; Nitta Y; Matsuoka M; Sasaki S; Sugimoto S; Uchiyama T; Morita K; Kasai T; Kawaguchi R; Ohbayashi C
    Hum Pathol; 2021 May; 111():59-66. PubMed ID: 33667423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of BRCA1-associated protein-1, glucose transporter-1 and desmin expression in the discrimination between reactive mesothelial proliferation and malignant mesothelioma in tissues and effusions.
    Önder S; Özogul E; Koksal D; Sarinc Ulasli S; Firat P; Emri S
    Cytopathology; 2019 Nov; 30(6):592-600. PubMed ID: 31165505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.